Michel Tellier

15PUBLICATIONS
30CO-AUTHORS
Molecular targetsIndustrial molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMicroelectromechanical systems (MEMS)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Feb 20, 2026
NELF prevents transcriptional readthrough into DNA replication zones in cancer cells.

Chihiro Nakayama, Qi Fang, Yasukazu Daigaku

|Oct 21, 2024
Isoginkgetin and Madrasin are poor splicing inhibitors.

Michael Tellier, Gilbert Ansa, Shona Murphy

|Feb 14, 2024
NELF coordinates Pol II transcription termination and DNA replication initiation.

Chihiro Nakayama, Yasukazu Daigaku, Yuki Aoi

|Sep 21, 2023
APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer.

Jennifer L McCann, Agnese Cristini, Emily K Law

|Jun 12, 2023
Regulation of mature mRNA levels by RNA processing efficiency.

Callum Henfrey, Shona Murphy, Michael Tellier

|Feb 06, 2023
Regulation of immunological tolerance by the p53-inhibitor iASPP.

Elliot H Akama-Garren, Paul Miller, Thomas M Carroll

Pageof 3